Hungary - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Hungary Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 7.8% year on year. In 2019, the country was ranked number 236 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 16 Cases. India lead the ranking with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 16.00 |
2018 | 16.00 |
2017 | 16.00 |
2016 | 18.00 |
2015 |
Download all data from 2005 to 2019
How does Hungary rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
229 |
#229
Sweden
|
17 | 2019 | +6.3 % | -1.1 % | View data | |
236 |
#236
Hungary
|
16 | 2019 | +0.0 % | +7.8 % | View data | |
239 |
#239
Guyana
|
15 | 2019 | +7.1 % | +30.3 % | View data |